Why Taranaki women choose to have a mastectomy when suitable for breast conservation treatment

ANZ Journal of Surgery

Volumn 79, Issue 9, 2009, Pages 604-609

  Gollop, Susan J ^a,b   Kyle, Stephen M ^a   Fancourt, Michael W ^a   Gilkison, William T C ^a   Mosquera, Damien A ^a  

^a TARANAKI BASE HOSPITAL   (New Zealand)

^b NONE   (New Zealand)

Author keywords

Mastectomy; Operative surgical procedures; Radiotherapy; Segmental mastectomy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CONSERVATION TREATMENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; NEW ZEALAND; ORGAN PRESERVATION; PATIENT DECISION MAKING; PATIENT GUIDANCE; PROSPECTIVE STUDY; QUESTIONNAIRE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHOICE BEHAVIOR; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEW ZEALAND; RADIOTHERAPY;

EID: 69949107681     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2009.05014.x     Document Type: Article

References (15)

1. Veronesi U, Cascinelli N, Mariani L et al. Twenty year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N. Engl. J. Med. 2002 347 : 1227 1232.
2. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1995 333 : 1456 1461.
3. van Dongen JA, Voogd AC, Fentiman IS et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J. Natl. Cancer Inst. 2000 92 : 1143 1150.
4. Locker GY, Sainsbury JR, Cuzick J, Group AT. Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy. Cancer 2004 101 : 735 740. (Pubitemid 39030928)
5. Adelson P, Lim K, Churches T, Nguyen R. Surgical treatment of breast cancer in New South Wales 1991, 1992. ANZ J. Surg. 1997 67 : 9 14.
6. Chagpar AB, Studts JL, Scoggins CR et al. Factors associated with surgical options for breast carcinoma. Cancer 2006 106 : 1462 1466.
7. Meden T, St John-Larkin C, Hermes D, Sommerschield S. MSJAMA. Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan. JAMA 2002 287 : 111.
8. Neave L, Harvey V, Benjamin C et al. The Auckland Breast Cancer Register: a special project of the Auckland Breast Cancer Study Group. N. Z. Med. J. 2003 116 : U648.
9. Lee DWG, Vallance S. Surgical management of breast cancer in a small peripheral New Zealand hospital. ANZ J. Surg. 2006 76 : 1060 1063.
10. Meden T, St. John-Larkin C, Hermes D, Sommerschield S. Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan. JAMA 2002 287 : 111.
11. Irwig L, Bennetts A. Quality of life after breast conservation or mastectomy: a systematic review. ANZ J. Surg. 1997 67 : 750 754.
12. Moyer A. Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol. 1997 16 : 284 298.
13. Pusic A, Thompson TA, Kerrigan CL et al. Surgical options for the early-stage breast cancer: factors associated with patient choice and postoperative quality of life. Plast. Reconstr. Surg. 1999 104 : 1325 1333.
14. Curran D, van Dongen JP, Aaronson NK et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). Eur. J. Cancer 1998 34 : 307 314.
15. Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ 1990 301 : 575 580.